<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03561714</url>
  </required_header>
  <id_info>
    <org_study_id>CEDAR</org_study_id>
    <nct_id>NCT03561714</nct_id>
  </id_info>
  <brief_title>Cardiometabolic Care-team Integration Improves Outcomes in Diabetes</brief_title>
  <official_title>CARDIOMETABOLIC CARE-TEAM INTEGRATION IN PRIMARY CARE IMPROVES OUTCOMES IN DIABETES: A PRAGMATIC, CASE-CONTROLLED STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scripps Whittier Diabetes Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Scripps Whittier Diabetes Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pragmatic, quasi-experimental (non-randomized) design was used to evaluate clinical and
      cost outcomes among patients with type 1 or 2 diabetes (T1D or T2D) at two primary care
      clinics (n=1 intervention, n=1 usual care) between March 2012 and September 2014. At the
      intervention clinic, the 12-month Cardio-metabolic Care-Team Intervention (CMC-TI) was
      delivered to all qualifying patients; surveys were administered to evaluate relevant
      patient-reported outcomes over 12 months, and a process evaluation gauged CMC-TI feasibility
      and satisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2012</start_date>
  <completion_date type="Actual">December 30, 2014</completion_date>
  <primary_completion_date type="Actual">September 30, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>12 months</time_frame>
    <description>Change in HbA1c between Intervention and Comparator sites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital/ER costs</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL</measure>
    <time_frame>12 months</time_frame>
    <description>Change in LDL between Intervention and Comparator sites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Change in blood pressure between Intervention and Comparator sites</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">475</enrollment>
  <condition>Cardio-metabolic Care-Team Intervention (CMC-TI)</condition>
  <arm_group>
    <arm_group_label>CMC-TI</arm_group_label>
    <description>Cardiometabolic Care Team Intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Intervention Comparator site</arm_group_label>
    <description>Non intervention comparator site with usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cardometabolic Team Intervention</intervention_name>
    <description>The CMC-TI team included a registered nurse/certified diabetes educator (RN/CDE) Care Manager, medical assistant (MA) Health Coach, and RN Depression Care Manager. Decision support tools guided therapy for glucose, BP, low-density lipoprotein cholesterol (LDL-c), and depression. At the intervention clinic, the 12-month CMC-TI was delivered to all qualifying patients; surveys were administered to evaluate relevant patient-reported outcomes over 12 months.</description>
    <arm_group_label>CMC-TI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - All patients with type 1 and type 2 diabetes within two primary care clinics at Scripps
        Coastal Medical Group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with type 1 and type 2 diabetes

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 2, 2018</study_first_submitted>
  <study_first_submitted_qc>June 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <last_update_submitted>June 17, 2018</last_update_submitted>
  <last_update_submitted_qc>June 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scripps Whittier Diabetes Institute</investigator_affiliation>
    <investigator_full_name>Athena Philis-Tsimikas</investigator_full_name>
    <investigator_title>Corporate Vice President</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

